| D07086 | |
| D number | D07086 |
| Classification | Drug |
| Name | Rivaroxaban (JAN/USAN/INN); Xarelto (TN) |
| Component | - |
| Formula | C19H18ClN3O5S |
| Exact mass | 435.0656 |
| Mol weight | 435.8813 |
| Structural formula |  |
| Sequence | - |
| Sequence type | - |
| Source | - |
| Upper DGroup | Cardiovascular agent DG01662 Factor Xa inhibitor DG01950 Antithrombotic agent DG01662 Factor Xa inhibitor Cyp substrate DG01633 CYP3A substrate Transporter substrate DG01665 P-glycoprotein substrate |
| Remark | Therapeutic category: 3339 ATC code: B01AF01 |
| Activity | - |
| Disease | - |
| Comment | Prophylaxis of venous thromboembolism |
| Target | F10 [HSA:2159] [KO:K01314] |
| Metabolism | Enzyme: CYP3A4 [HSA:1576], CYP3A5 [HSA:1577], CYP2J2 [HSA:1573] Transporter: ABCB1 [HSA:5243] |
| Interaction | |
| Other DBs | CAS: 366789-02-8 PubChem: 51091428 ChEBI: 68579 ChEMBL: CHEMBL198362 PDB-CCD: RIV LigandBox: D07086 NIKKAJI: J2.395.184C |
| KCF data | - |